Design, synthesis and in vitro antiproliferation activity of some 2-aryl and -heteroaryl benzoxazole derivatives

ArticleAçık Erişim

Özet

Background: Phortress produces reactive electrophilic metabolites that form DNA adducts only in sensitive tumor cells. The authors converted the 2-phenylbenzothiazole nucleus in phortress to 2-aryl and -heteroaryl benzoxazole derivatives (11 new and 14 resynthesized). All synthesized compounds were studied for antitumor activity in various cancer cells. Materials & methods: Cytotoxicity, cell morphology, flow cytometry and cell-cycle analyses of compounds were performed and more active derivatives were tested in the MCF-7 cell line. Conclusion: Methyl 2-(thiophen-2-yl)benzo[d]oxazole-6-carboxylate (BK89) has a higher effect than fluorouracil to induce apoptotic cell death (apoptosis value of 49.44%). Cell-cycle analysis shows that the compounds BK89 and methyl 2-(furan-2-yl)benzo[d]oxazole-6-carboxylate (BK82) can be used as potential cell-cycle blockers by arresting MCF-7 cells in G0/G1 phase at rates of 63% and 85%, respectively. Plain language summary There is an urgent need to develop potent and selective anticancer agents. In this study, the design and applications of compounds sensitive to specific cancer cells and targeting cancer cells were investigated. The results show that the synthesized compounds can be antiproliferative drug candidates for breast cancer. These compounds may shed light on cancer treatment and cancer research. © 2022 Newlands Press.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12923Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.4155/fmc-2022-0076Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKuzu, Burak
dc.contributor.authorHepokur, Ceylan
dc.contributor.authorTurkmenoglu, Burcin
dc.contributor.authorBurmaoglu, Serdar
dc.contributor.authorAlgul, Oztekin
dc.date.accessioned2026-10-18T20:27:46.582134729Z
dc.date.available2026-10-18T20:27:46.582134729Z
dc.date.issued2022
dc.description.abstractBackground: Phortress produces reactive electrophilic metabolites that form DNA adducts only in sensitive tumor cells. The authors converted the 2-phenylbenzothiazole nucleus in phortress to 2-aryl and -heteroaryl benzoxazole derivatives (11 new and 14 resynthesized). All synthesized compounds were studied for antitumor activity in various cancer cells. Materials & methods: Cytotoxicity, cell morphology, flow cytometry and cell-cycle analyses of compounds were performed and more active derivatives were tested in the MCF-7 cell line. Conclusion: Methyl 2-(thiophen-2-yl)benzo[d]oxazole-6-carboxylate (BK89) has a higher effect than fluorouracil to induce apoptotic cell death (apoptosis value of 49.44%). Cell-cycle analysis shows that the compounds BK89 and methyl 2-(furan-2-yl)benzo[d]oxazole-6-carboxylate (BK82) can be used as potential cell-cycle blockers by arresting MCF-7 cells in G0/G1 phase at rates of 63% and 85%, respectively. Plain language summary There is an urgent need to develop potent and selective anticancer agents. In this study, the design and applications of compounds sensitive to specific cancer cells and targeting cancer cells were investigated. The results show that the synthesized compounds can be antiproliferative drug candidates for breast cancer. These compounds may shed light on cancer treatment and cancer research. © 2022 Newlands Press.
dc.identifier.doi10.4155/fmc-2022-0076
dc.identifier.eissn1756-8927
dc.identifier.endpage1048
dc.identifier.issn1756-8919
dc.identifier.issue14
dc.identifier.pmid35703122
dc.identifier.scopus2-s2.0-85133103368
dc.identifier.startpage1027
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12923
dc.identifier.volume14
dc.identifier.wosWOS:000810906900001
dc.language.isoen
dc.publisherFuture Medicine Ltd.
dc.relation.ispartofFuture Medicinal Chemistry
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectapoptosis
dc.subjectbenzoxazole
dc.subjectcell-cycle
dc.subjectcytotoxicity
dc.subjectflow cytometry
dc.subjectmolecular docking
dc.subjectphortress
dc.subjectAntineoplastic Agents
dc.subjectBenzoxazoles
dc.subjectCell Line, Tumor
dc.subjectCell Proliferation
dc.subjectDose-Response Relationship, Drug
dc.subjectDrug Screening Assays, Antitumor
dc.subjectHumans
dc.subjectMolecular Docking Simulation
dc.subjectMolecular Structure
dc.subjectOxazoles
dc.subjectStructure-Activity Relationship
dc.subject2 (4 methoxyphenyl) 6 methylbenzo[d]oxazole
dc.subject2 (furan 2 il) 6 nitrobenzo[d]oksazol
dc.subject2 (furan 2 yl)benzo[d]oxazole
dc.subject2 (thiophen 2 yl)benzo[d]oxazole
dc.subject2 aryl benzoxazole derivative
dc.subject2 heteroaryl benzoxazole derivative
dc.subject2 phenylbenzothiazole
dc.subject2 phenylbenzo[d]oxazole
dc.subject2 [(1,1 biphenyl) 4 yl] 6 methylbenzo[d]oxazole
dc.subject4 (6 methylbenzo[d]oxazol 2 yl)benzonitrile
dc.subject5 chloro 2 (furan 2 il)benzo[d]oksazol
dc.subject5 chloro 2 (thiophen 2 yl)benzo[d]oxazole
dc.titleDesign, synthesis and in vitro antiproliferation activity of some 2-aryl and -heteroaryl benzoxazole derivatives
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus23
rdl.citation.wos20
rdl.departmentDepartment of Analytical Chemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, 24100, Turkey. | Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, 24100, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)